Total Payments
$307,146
2024 Payments
$53,871
Companies
27
Transactions
457
Medicare Patients
17,952
Medicare Billing
$11.4M
Payment Breakdown by Category
Other$132,620 (43.2%)
Consulting$123,989 (40.4%)
Travel$33,153 (10.8%)
Food & Beverage$17,233 (5.6%)
Education$131.00 (0.0%)
Gifts$19.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $132,620 | 30 | 43.2% |
| Consulting Fee | $123,989 | 50 | 40.4% |
| Travel and Lodging | $33,153 | 74 | 10.8% |
| Food and Beverage | $17,233 | 300 | 5.6% |
| Education | $131.00 | 2 | 0.0% |
| Gift | $19.40 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $179,453 | 207 | $0 (2024) |
| Alcon Research LLC | $51,980 | 25 | $0 (2024) |
| Alcon Vision LLC | $26,403 | 63 | $0 (2024) |
| Alcon Laboratories Inc | $17,470 | 22 | $0 (2018) |
| Allergan, Inc. | $13,190 | 30 | $0 (2021) |
| Carl Zeiss Meditec, Inc. | $10,458 | 4 | $0 (2021) |
| Regeneron Pharmaceuticals, Inc. | $2,529 | 2 | $0 (2024) |
| Beaver-Visitec International, Inc. | $2,100 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,440 | 41 | $0 (2024) |
| EyePoint Pharmaceuticals US, Inc. | $324.87 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53,871 | 80 | Genentech USA, Inc. ($36,894) |
| 2023 | $61,522 | 91 | Genentech USA, Inc. ($51,117) |
| 2022 | $53,987 | 77 | Genentech USA, Inc. ($48,199) |
| 2021 | $43,243 | 37 | Genentech USA, Inc. ($13,762) |
| 2020 | $12,501 | 25 | Alcon Research LLC ($8,400) |
| 2019 | $39,613 | 69 | Genentech USA, Inc. ($16,762) |
| 2018 | $29,484 | 43 | Alcon Laboratories Inc ($15,203) |
| 2017 | $12,924 | 35 | Genentech USA, Inc. ($5,854) |
All Payment Transactions
457 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Beaver-Visitec International, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| 12/16/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: Ophthalmology | ||||||
| 12/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Travel and Lodging | Cash or cash equivalent | $225.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Travel and Lodging | Cash or cash equivalent | $225.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Travel and Lodging | Cash or cash equivalent | $112.39 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Travel and Lodging | Cash or cash equivalent | $68.79 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Travel and Lodging | Cash or cash equivalent | $35.92 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | Cash or cash equivalent | $29.08 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/11/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/10/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Ophthalmology | ||||||
| 12/06/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,640.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/06/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,640.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/05/2024 | Alcon Research LLC | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Ophthalmology | ||||||
| 11/20/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: EYE CARE | ||||||
| 11/07/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Travel and Lodging | In-kind items and services | $552.20 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/07/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Travel and Lodging | In-kind items and services | $255.18 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/07/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $104.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/29/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $4.40 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/26/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $78.57 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/26/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $63.30 | General |
| Category: Immunology and Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 4,769 | 34,604 | $7.8M | $2.6M |
| 2022 | 19 | 4,573 | 19,572 | $7.0M | $2.8M |
| 2021 | 17 | 4,341 | 17,358 | $7.0M | $3.0M |
| 2020 | 17 | 4,269 | 16,951 | $8.5M | $3.0M |
Total Patients
17,952
Total Services
88,485
Medicare Billing
$11.4M
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 182 | 5,440 | $3.5M | $965,358 | 27.3% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 56 | 18,720 | $936,000 | $544,862 | 58.2% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 66 | 778 | $1.2M | $522,563 | 44.7% |
| 67028 | Injection of drug into eye | Office | 2023 | 305 | 2,010 | $1.1M | $194,648 | 18.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 958 | 1,370 | $391,820 | $138,979 | 35.5% |
| 92134 | Imaging of retina | Office | 2023 | 1,206 | 3,290 | $302,680 | $110,799 | 36.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 243 | 375 | $75,750 | $28,685 | 37.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 187 | 187 | $68,068 | $24,258 | 35.6% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 1,020 | 1,663 | $59,868 | $21,085 | 35.2% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 15 | 15 | $38,550 | $15,030 | 39.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 112 | $24,711 | $10,464 | 42.3% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 32 | 124 | $47,000 | $8,798 | 18.7% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 260 | 347 | $19,432 | $7,004 | 36.0% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 47 | 47 | $13,815 | $6,014 | 43.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 29 | $10,719 | $4,230 | 39.5% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 46 | 57 | $6,840 | $2,411 | 35.2% |
| 92250 | Photography of the retina | Office | 2023 | 29 | 29 | $3,016 | $919.98 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $2,070 | $881.54 | 42.6% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 201 | 6,523 | $3.9M | $1.4M | 37.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 73 | 890 | $1.3M | $624,359 | 48.0% |
| 67028 | Injection of drug into eye | Office | 2022 | 292 | 2,043 | $461,718 | $195,620 | 42.4% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 946 | 1,298 | $371,086 | $131,879 | 35.5% |
| 92134 | Imaging of retina | Office | 2022 | 1,163 | 3,269 | $300,702 | $110,079 | 36.6% |
| J3590 | Unclassified biologics | Office | 2022 | 17 | 55 | $220,000 | $100,656 | 45.8% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 25 | 2,700 | $135,000 | $80,572 | 59.7% |
About Dr. Charles Eifrig, M.D
Dr. Charles Eifrig, M.D is a Ophthalmology healthcare provider based in Laguna Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306812979.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Eifrig, M.D has received a total of $307,146 in payments from pharmaceutical and medical device companies, with $53,871 received in 2024. These payments were reported across 457 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($132,620).
As a Medicare-enrolled provider, Eifrig has provided services to 17,952 Medicare beneficiaries, totaling 88,485 services with total Medicare billing of $11.4M. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Retina Specialist
- Location Laguna Hills, CA
- Active Since 02/24/2006
- Last Updated 03/31/2017
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1306812979
Products in Payments
- Vabysmo (Drug) $71,265
- Lucentis (Biological) $47,205
- VABYSMO (Drug) $44,420
- Constellation (Device) $36,486
- OZURDEX (Drug) $13,353
- CLARUS 700 (Device) $10,350
- Susvimo (Drug) $8,957
- NGENUITY (Device) $6,225
- Centurion (Device) $3,519
- EYLEA HD (Biological) $2,934
- Luxor (Device) $2,100
- EYLEA (Biological) $847.21
- YUTIQ (Drug) $321.40
- SUSVIMO (Drug) $252.12
- EVA Ophthalmic Surgical System (Device) $193.09
- ILUVIEN (Drug) $191.78
- Syfovre (Drug) $191.26
- EYLEA AFLIBERCEPT INJECTION (Biological) $188.25
- Cimerli (Biological) $171.13
- Izervay (Drug) $139.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Laguna Hills
Savak Teymoorian, M.d, M.D
Ophthalmology — Payments: $1.0M
Ophthalmology $1.0M
John Hovanesian, M.d, M.D
Ophthalmology — Payments: $945,377
Ophthalmology $945,377
Duna Raoof, Md, MD
Ophthalmology — Payments: $86,235
Ophthalmology $86,235
Diana Kersten, M.d, M.D
Ophthalmology — Payments: $32,766
Ophthalmology $32,766
George Salib, Md, MD
Ophthalmology — Payments: $18,614
Ophthalmology $18,614
Jonathan Pirnazar, Md, MD
Ophthalmology — Payments: $16,822
Ophthalmology $16,822